SU1011126A1
(ru)
*
|
1981-07-14 |
1983-04-15 |
Всесоюзный научно-исследовательский и испытательный институт медицинской техники |
Средство дл лечени сахарного диабета
|
FI78616C
(fi)
*
|
1982-02-05 |
1989-09-11 |
Novo Industri As |
Foerfarande foer framstaellning av en foer infusionsaendamaol avsedd stabiliserad insulinloesning, som har en foerhoejd zinkhalt.
|
US4609546A
(en)
*
|
1982-06-24 |
1986-09-02 |
Japan Chemical Research Co., Ltd. |
Long-acting composition
|
US4457916A
(en)
*
|
1982-08-31 |
1984-07-03 |
Asahi Kasei Kogyo Kabushiki Kaisha |
Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same
|
DE3325223A1
(de)
*
|
1983-07-13 |
1985-01-24 |
Hoechst Ag, 6230 Frankfurt |
Gegen denaturierung bestaendige, waessrige proteinloesungen, verfahren zu ihrer herstellung und ihre verwendung
|
CA1244347A
(en)
*
|
1984-05-29 |
1988-11-08 |
Eddie H. Massey |
Stabilized insulin formulations
|
US4839341A
(en)
*
|
1984-05-29 |
1989-06-13 |
Eli Lilly And Company |
Stabilized insulin formulations
|
DE3443877A1
(de)
*
|
1984-06-09 |
1985-12-12 |
Hoechst Ag |
Insulinzubereitungen, verfahren zu deren herstellung und deren verwendung
|
AU626840B2
(en)
*
|
1988-02-26 |
1992-08-13 |
Genentech Inc. |
Human relaxin formulation
|
US5981485A
(en)
|
1997-07-14 |
1999-11-09 |
Genentech, Inc. |
Human growth hormone aqueous formulation
|
IL87055A
(en)
*
|
1988-07-08 |
1994-06-24 |
Illana Gozes |
Conjugates of vasoactive intestinal peptide (vip) and of fragments thereof and pharmaceutical compositions comprising them
|
US5447912A
(en)
*
|
1989-09-18 |
1995-09-05 |
Senetek, Plc |
Erection-inducing methods and compositions
|
US5830452A
(en)
*
|
1990-11-20 |
1998-11-03 |
Chiron Corporation |
Method for enhancing the anti-tumor therapeutic index of interleukin-2
|
DE19722950A1
(de)
*
|
1997-05-31 |
1998-12-03 |
Huels Chemische Werke Ag |
Renaturierung von Eiweißstoffen
|
DE19726167B4
(de)
|
1997-06-20 |
2008-01-24 |
Sanofi-Aventis Deutschland Gmbh |
Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
|
ES2179414T3
(es)
|
1997-11-22 |
2003-01-16 |
Roche Diagnostics Gmbh |
Procedimiento mejorado de estabilizacion de proteinas.
|
US6852694B2
(en)
|
2001-02-21 |
2005-02-08 |
Medtronic Minimed, Inc. |
Stabilized insulin formulations
|
DE10114178A1
(de)
|
2001-03-23 |
2002-10-10 |
Aventis Pharma Gmbh |
Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
|
US6737401B2
(en)
*
|
2001-06-28 |
2004-05-18 |
Metronic Minimed, Inc. |
Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
|
DE10227232A1
(de)
|
2002-06-18 |
2004-01-15 |
Aventis Pharma Deutschland Gmbh |
Saure Insulinzubereitungen mit verbesserter Stabilität
|
EP2077132A1
(en)
|
2008-01-02 |
2009-07-08 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device, storage device and method for dispensing a formulation
|
EP2310412B1
(en)
|
2008-06-20 |
2018-02-21 |
Novartis AG |
Immunoglobulins with reduced aggregation
|
PT3228320T
(pt)
|
2008-10-17 |
2020-03-26 |
Sanofi Aventis Deutschland |
Combinação de uma insulina e de um agonista do glp-1
|
WO2010112358A2
(de)
|
2009-03-31 |
2010-10-07 |
Boehringer Ingelheim International Gmbh |
Verfahren zur beschichtung einer oberfläche eines bauteils
|
US9265910B2
(en)
|
2009-05-18 |
2016-02-23 |
Boehringer Ingelheim International Gmbh |
Adapter, inhalation device, and nebulizer
|
US10029011B2
(en)
|
2009-11-13 |
2018-07-24 |
Sanofi-Aventis Deutschland Gmbh |
Pharmaceutical composition comprising a GLP-1 agonist, an insulin and methionine
|
PT2498801T
(pt)
|
2009-11-13 |
2018-05-02 |
Sanofi Aventis Deutschland |
Composição farmacêutica compreendendo despro36exendin-4(1-39)-lys6-nh2 e metionina
|
JP5658268B2
(ja)
|
2009-11-25 |
2015-01-21 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ネブライザ
|
AU2010323220B2
(en)
|
2009-11-25 |
2015-04-23 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
US10016568B2
(en)
|
2009-11-25 |
2018-07-10 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
US20130017197A1
(en)
|
2010-03-31 |
2013-01-17 |
Universite De Geneve |
Stabilized antibody preparations and uses thereof
|
WO2011121560A2
(en)
|
2010-03-31 |
2011-10-06 |
Universite De Geneve |
Stabilized antibody preparations and uses thereof
|
JP5874724B2
(ja)
|
2010-06-24 |
2016-03-02 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ネブライザ
|
SG187904A1
(en)
|
2010-08-30 |
2013-04-30 |
Sanofi Aventis Deutschland |
Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
|
EP2694220B1
(de)
|
2011-04-01 |
2020-05-06 |
Boehringer Ingelheim International GmbH |
Medizinisches gerät mit behälter
|
US9821032B2
(en)
|
2011-05-13 |
2017-11-21 |
Sanofi-Aventis Deutschland Gmbh |
Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
|
US9827384B2
(en)
|
2011-05-23 |
2017-11-28 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
KR101983982B1
(ko)
|
2011-08-29 |
2019-05-30 |
사노피-아벤티스 도이칠란트 게엠베하 |
2형 당뇨병 환자의 혈당 조절에 사용하기 위한 약제학적 병용물
|
AR087744A1
(es)
|
2011-09-01 |
2014-04-16 |
Sanofi Aventis Deutschland |
Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
|
WO2013152894A1
(de)
|
2012-04-13 |
2013-10-17 |
Boehringer Ingelheim International Gmbh |
Zerstäuber mit kodiermitteln
|
EA034393B1
(ru)
|
2012-11-13 |
2020-02-03 |
Адосиа |
Состав инсулина быстрого действия, содержащий замещенное анионное соединение
|
WO2015018904A1
(en)
|
2013-08-09 |
2015-02-12 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
EP2835146B1
(en)
|
2013-08-09 |
2020-09-30 |
Boehringer Ingelheim International GmbH |
Nebulizer
|
US10722666B2
(en)
|
2014-05-07 |
2020-07-28 |
Boehringer Ingelheim International Gmbh |
Nebulizer with axially movable and lockable container and indicator
|
UA121114C2
(uk)
|
2014-05-07 |
2020-04-10 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
Небулайзер, індикаторний пристрій і контейнер
|
MX2016014400A
(es)
|
2014-05-07 |
2017-01-20 |
Boehringer Ingelheim Int |
Recipiente, nebulizador y uso.
|
NZ733670A
(en)
|
2014-12-12 |
2021-12-24 |
Sanofi Aventis Deutschland |
Insulin glargine/lixisenatide fixed ratio formulation
|
AR102869A1
(es)
|
2014-12-16 |
2017-03-29 |
Lilly Co Eli |
Composiciones de insulina de rápida acción
|
TWI748945B
(zh)
|
2015-03-13 |
2021-12-11 |
德商賽諾菲阿凡提斯德意志有限公司 |
第2型糖尿病病患治療
|
TW201705975A
(zh)
|
2015-03-18 |
2017-02-16 |
賽諾菲阿凡提斯德意志有限公司 |
第2型糖尿病病患之治療
|
JO3749B1
(ar)
|
2015-08-27 |
2021-01-31 |
Lilly Co Eli |
تركيبات إنسولين سريعة المفعول
|
EA201992351A1
(ru)
|
2017-06-01 |
2020-03-26 |
Эли Лилли Энд Компани |
Быстродействующие композиции инсулина
|